期刊文献+

EZH2在前列腺癌中的表达及其与临床病理的关系 被引量:9

EZH2 expression in human prostate cancer and its clinicopathologic significance
下载PDF
导出
摘要 目的:探讨EZH2蛋白及其mRNA在前列腺癌中的表达以及两者与临床病理参数间的关系。方法:通过组织芯片技术,运用免疫组化(EnVision法)和原位杂交方法分别检测48例前列腺癌中EZH2蛋白及其mRNA的表达,同时检测常规石蜡组织中15例良性前列腺增生组织和12例高级别上皮内瘤变组织中的EZH2蛋白及其mRNA的表达作为对照。结果:EZH2蛋白和mRNA在前列腺癌中的阳性率(87.5%、81.25%)明显高于良性前列腺增生组织(13.33%、6.67%)和高级别上皮内瘤(16.67%、16.67%),差异有统计学意义(P<0.05)。免疫组化显示,EZH2蛋白在Gleason≥7分组阳性表达率(96.67%)明显高于Gleason≤6分组(72.22%),差异有统计学意义(P<0.05)。EZH2蛋白阳性表达率与TNM分期比较,T3~T4期(100%)明显高于T1~T2期(76.92%),亦有统计学意义(P<0.05),而EZH2蛋白表达与年龄和PSA无关(P>0.05)。原位杂交显示,EZH2mRNA的阳性表达率T3~T4期(100%)高于T1~T2期(85%),与TNM分期显著相关(P<0.05),而与年龄、PSA和Gleason分级无关(P>0.05)。分段评价预后估计较好组与预后估计较差组,两组之间EZH2蛋白及其mRNA表达阳性率均有显著性差异(P<0.05)。结论:EZH2蛋白及其mRNA在前列腺癌中高表达,提示其在前列腺癌的发生、发展过程中可能起重要作用,有可能成为判定前列腺癌恶性程度进程和预后的参考指标。 Objective:To investigate the expressions of the EZH2 protein and EZH2 mRNA in human prostate cancer(PCa) and their correlation with the clinicopathologic parameters.Methods:A tissue microarray(TMA) was constructed,which contained 48 dots of formalin-fixed paraffin-embedded tissue samples of human PCa.The expressions of the EZH2 protein and EZH2 mRNA in the samples were detected by immunohistochemistry(EnVision) and in situ hybridization(ISH).Another 15 cases of human benign prostate hyperplasia(BPH) and 12 cases of human prostate intraepithelial neoplasia(HGPIN) were taken as controls.Results:The positive rates of the EZH2 protein and mRNA were significantly higher in PCa than in BPH and HGPIN(87.5%vs 13.33%and 16.67%,81.25%vs 6.67%and 16.67%,P〈0.05).The positive expression of the EZH2 protein was 96.67%and 72.22%in the Gleason score≥7 and Gleason score≤6 groups,respectively,with significant differences between the two groups(P〈0.05). The positivity of the EZH2 protein was significantly related to the TNM stage,increasing with tumor progression(P〈0.05),but not to age and serum PSA(P〈0.05),and so was that of EZH2 mRNA to TNM stage(P〈0.05),but not to age,serum PSA and Gleason score(P〈0.05).When the above characteristics were regarded as two-level discrete variables,both the EZH2 protein and EZH2 mRNA showed statistically significant differences in the positive expression rate(P〈0.05).Conclusion:The over-expressions of the EZH2 protein and EZH2 mRNA may play an important role in the pathogenesis and progression of PCa and provide some reference indexes for estimating the malignancy,progression and prognosis of PCa.
出处 《中华男科学杂志》 CAS CSCD 北大核心 2010年第2期123-128,共6页 National Journal of Andrology
关键词 前列腺肿瘤 EZH2 组织芯片 免疫组化 原位杂交 prostatic neoplasm EZH2 tissue microarray immunohistochemistry in situ hybridization
  • 相关文献

参考文献13

  • 1李江,范钦和.EZH2在恶性肿瘤中的相关研究[J].中华病理学杂志,2009,38(12):856-858. 被引量:2
  • 2Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue mieroarrays for high-throughput molecular profiling of tumor specimens. Nat Med, 1998, 4(7) : 844-847. 被引量:1
  • 3李燕,石群立,金行藻,孟奎,周晓军,孙丽萍.组织芯片检测前列腺癌中BRG1表达的研究[J].中华男科学杂志,2006,12(7):629-632. 被引量:10
  • 4Hobert O, Jallal B, Ullrich A. Interaction of Vav with ENX-1, a putative transcriptional regulator of horneobox gene expression. Mol Cell Biol, 1996, 16(6) : 3066-3073. 被引量:1
  • 5Cardoso C, Mignon C, Hetet G, et al. The human EZH2 gene: Genomic organisation and revised mapping in 7q35 within the critical region for malignant myeloid disorders. Eur J Hum Genet, 2000, 8(3) : 174-180. 被引量:1
  • 6Kuzmichev A, Jenuwein T, Tempst P, et al. Different EZH2- containing complexes target methylation of histone H1 or nueleosomal histone H3. Mol Cell, 2004, 14(2) : 183-193. 被引量:1
  • 7Kleer CG, Cao Q, Varambally S, et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci U S A, 2003, 100 (20) : 11606-11611. 被引量:1
  • 8Chen H, Tu SW, Hsieh JT. Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer. J Biol Chem, 2005, 280 (23) : 22437 -22444. 被引量:1
  • 9Varambally S, Dhanasekaran SM, Zhou M, et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature, 2002, 419(6907): 624-629. 被引量:1
  • 10Tusher VG, Tibshiranl R, Chu G. Significance analysis of microarrays applied to the ionizing radiation reponse. Proc Natl Acad Sci U S A, 2001, 98(9) : 5116-5121. 被引量:1

二级参考文献42

  • 1李青,周晓军,谢海龙,苏宁,邓红,孟奎.胃癌中BRG1蛋白的表达及意义[J].临床与实验病理学杂志,2004,20(4):402-405. 被引量:4
  • 2石群立,周晓军,孟奎,陈琴,盛春宁,李军,陈鑫,刘镭.穿孔素与颗粒酶B在鼻NK/T细胞淋巴瘤诊断中的意义[J].临床与实验病理学杂志,2004,20(5):580-584. 被引量:9
  • 3唐爱发,蔡志明.DNA芯片在男科学研究中的应用[J].中华男科学杂志,2005,11(9):686-688. 被引量:1
  • 4彭燕,陈海滨,苏中静,陈玲,张锦,许丽艳.EZH2蛋白在食管癌组织中的表达[J].解剖学报,2006,37(6):650-655. 被引量:6
  • 5Hobert O, Jallal B, Ulrich A. Interaction of Vav with ENX-1, a putative transcriptional regulator of homeobox gene expression. Mol Cell Biol, 1996,16 (6) : 3066-3073. 被引量:1
  • 6Cardoso C, Mignon C, Hetet G, et al. The human EZH2 gene: genomic organisation and revised mapping in 7q35 within the critical region for malignant myeloid disorders. Eur J Hum Genet, 2000,8(3) :174-180. 被引量:1
  • 7Bracken AP, Pasini D, Capra M, et al. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J.2003.22(20):5323-5335. 被引量:1
  • 8Kuzmichev A, Jenuwein T, Tempst P, et al. Different EZH2- containing complexes target methylation of histone H1 or nucleosomal histone H3. Mol Cell,2004,14 (2) : 183-193. 被引量:1
  • 9Kleer CG, Cao Q, Varambally S, et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci U S A,2003,100(20) : 11606-11611. 被引量:1
  • 10Varambally S, Dhanasekaran SM, Zhou M, et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature ,2002,419 (6907) :624-629. 被引量:1

共引文献10

同被引文献64

引证文献9

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部